KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio (2016 - 2026)

TherapeuticsMD filings provide 15 years of Asset Utilization Ratio readings, the most recent being 0.09 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 86.54% to 0.09 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.09, a 86.54% increase, with the full-year FY2025 number at 0.08, up 84.29% from a year prior.
  • Asset Utilization Ratio hit 0.09 in Q1 2026 for TherapeuticsMD, up from 0.08 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.33 in Q3 2023 to a low of 0.03 in Q2 2024.
  • Median Asset Utilization Ratio over the past 5 years was 0.08 (2025), compared with a mean of 0.33.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 830.44% in 2023 and later crashed 97.82% in 2024.
  • TherapeuticsMD's Asset Utilization Ratio stood at 0.62 in 2022, then plummeted by 95.19% to 0.03 in 2023, then skyrocketed by 49.69% to 0.04 in 2024, then surged by 76.21% to 0.08 in 2025, then increased by 12.56% to 0.09 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.09 (Q1 2026), 0.08 (Q4 2025), and 0.07 (Q3 2025) per Business Quant data.